Landmark Bio™ Appoints Gregg Nyberg, Ph.D., as Chief Technology Officer and Michael Covington as Chief Quality and Regulatory Office adminddg | October 19, 2021
The Boston Globe: Harvard-MIT’s Landmark Bio hires California executive as CEO adminddg | July 29, 2021
The Harvard Gazette: Veteran biotech executive to run new center aimed at boosting cell and gene therapies adminddg | July 29, 2021
Worcester Business Journal: Cytiva named as founding member of Watertown biomanufacturing facility. adminddg | January 15, 2021
The Harvard Gazette: Big step forward for planned center to boost cell- and gene-therapy advances adminddg | January 14, 2021
The Harvard Crimson: Center for Advanced Biological Innovation and Manufacturing Secures $76 Million in Funding, Signs Lease adminddg | January 14, 2021
STAT: Facing bottlenecks in manufacturing cell therapies, Boston leaders plan to build their own adminddg | November 25, 2019
